Blue Earth Diagnostics
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Blue Earth Diagnostics
Seven new medicines, including GW Pharma's orphan cannabidiol product, Epidyolex, are due for an opinion from the European Medicines Agency this week on whether they should be recommended for pan-EU approval.
Bracco Imaging is paying $450m to buy Blue Earth Diagnostics from London-listed venture capital firm Syncona Investment Management Ltd.
The latest drug development news and highlights from our US FDA Performance Tracker.
Biopharma financing finished off 2017 strong with a total value of $14.5 billion in Q4, led again by FOPOs. CVS' massive $77 billion acquisition of Aetna resulted in an all-time quarterly high in the M&A category, and the largest alliances were dominated by the development of vaccines and antibodies.